Det danske screeningsprogram for hæmoglobinopatier

Andreas Glenthøj, Mie Samson, Nina Toft, Birgitte Rode Diness, Nikolaj Askj R, Fie Juhl Vojdeman, Henrik Birgens, Morten Beck Sørensen, Jesper Petersen


The prevalence of people in Denmark descending from areas with a high prevalence of haemoglobinopathies is approximately one tenth and increasing. Since 1995, the Danish Health Authority has recommended haemoglobinopathy screening of pregnant women with ethnic roots outside Northern Europe. Partners of pregnant haemoglobinopathy carriers are also tested. Carrier state in both parents leads to genetic counselling, and prenatal diagnostics of the foetus (chorionic villus biopsy or amniocentesis) is offered, which can lead to abortion and/or preimplantation genetic screening for future pregnancies, as discussed in this review.

Bidragets oversatte titelThe Danish screening programme for haemoglobinopathies: Det danske screeningsprogram for hæmoglobinopatier
TidsskriftUgeskrift for Laeger
Udgave nummer3
StatusUdgivet - 18 jan. 2021


  • Amniocentesis
  • Denmark/epidemiology
  • Europe
  • Female
  • Hemoglobinopathies/diagnosis
  • Humans
  • Pregnancy
  • Prenatal Diagnosis


Dyk ned i forskningsemnerne om 'Det danske screeningsprogram for hæmoglobinopatier'. Sammen danner de et unikt fingeraftryk.